by Joris Van Arensbergen | May 12, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 12, 2025 Orchard Therapeutics, a Kyowa Kirin company focused on innovative gene therapies, and Annogen B.V., experts in bespoke promoter design and gene expression engineering, today announced the successful identification of...
by Joris Van Arensbergen | May 7, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 7, 2025 Ascend Advanced Therapies and Annogen will combine their expertise in AAV biology, vector manufacturing and genetic engineering to improve the quality of recombinant AAV particles used in gene therapy applications. While AAV...
by admin | Feb 25, 2025 | Blog, SURE Technology
What makes Annogen’s promoter design stand-out from other providers? A valid question. Let’s put this in historical context. Gene promoter design is nothing new: as early as the 1980’s, researchers began to understand different components within promoters, e.g. TATA...
by admin | Dec 12, 2024 | News, SURE Technology
UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters Annogen, a leader in gene expression engineering, and the prestigious labs of Qizhi Tang and Brian Shy at University of California, San Francisco (UCSF) today announced a collaboration...
by admin | Nov 29, 2024 | News, SURE Technology
Article as featured in the Financieel Dagblad (Financial Times), 29 November 2024...
by admin | Oct 1, 2024 | Application notes, SURE Technology
standing the challenge: the right place, the right time The development of cell and gene therapies is a complex and time-consuming process that depends on therapeutic genes being expressed in the right tissues, at the right time and at the right dosage. A key...
